Screener
Fulgent Genetics, Inc. FLGT EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Fulgent Genetics, Inc.’s reported figures.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026. Open the filing →
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
FAQ
- What is Fulgent Genetics, Inc.'s EBITDA?
- Fulgent Genetics, Inc. (FLGT) reported EBITDA of -$28.62M in Q1 2026.
- How has Fulgent Genetics, Inc.'s EBITDA changed year-over-year?
- Fulgent Genetics, Inc.'s EBITDA decreased by 106.3% year-over-year, from -$13.88M to -$28.62M.
- What is the long-term trend for Fulgent Genetics, Inc.'s EBITDA?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s EBITDA has grown at a -44.1% compound annual growth rate (CAGR), from $686.96M to -$66.97M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Fulgent Genetics, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude